PLAQUENIL

This brand name is authorized in United States. It is also authorized in Australia, Canada, Cyprus, Estonia, France, Germany, Hong Kong SAR China, Ireland, Israel, Italy, Japan, Lithuania, Malta, Mexico, Netherlands, New Zealand, Romania, Singapore, Tunisia, Turkey.

Active ingredients

The drug PLAQUENIL contains one active pharmaceutical ingredient (API):

1	Hydroxychloroquine UNII 8Q2869CNVH - HYDROXYCHLOROQUINE SULFATE
	Hydroxychloroquine is a antimalarial agent with have several pharmacological actions which may be involved in their therapeutic effect in the treatment of rheumatic disease, but its role is not known.
	Read more about Hydroxychloroquine

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
PLAQUENIL Film coated tablet	MPI, EU: SmPC	Medicines and Medical Devices Safety Authority (NZ)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
P01BA02	Hydroxychloroquine	P Antiparasitic products, insecticides and repellents → P01 Antiprotozoals → P01B Antimalarials → P01BA Aminoquinolines
Discover more medicines within P01BA02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
AU	Pharmaceutical Benefits Scheme	12003R, 1512N
CA	Health Products and Food Branch	02017709
DE	Bundesinstitut für Arzneimittel und Medizinprodukte	06349471, 07544217, 09510808, 09519399, 12393803
EE	Ravimiamet	1027291, 1529579, 1566086, 1830529
FR	Base de données publique des médicaments	67767535
HK	Department of Health Drug Office	43759
IE	Health Products Regulatory Authority	41000
IL	מִשְׂרַד הַבְּרִיאוּת	481
IT	Agenzia del Farmaco	013967056
JP	医薬品医療機器総合機構	3999038F1029
LT	Valstybinė vaistų kontrolės tarnyba	1003250, 1080353, 1081249, 1084977
MT	Medicines Authority	MA1359/02501, PI1438/09301A
MX	Comisión Federal para la Protección contra Riesgos Sanitarios	258M2014
NL	Z-Index G-Standaard, PRK	51
NZ	Medicines and Medical Devices Safety Authority	5528
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W62084001, W62084002
SG	Health Sciences Authority	12213P
TN	Direction de la Pharmacie et du Médicament	6590011
TR	İlaç ve Tıbbi Cihaz Kurumu	8699809097872, 8699809097896, 8699809098688
US	FDA, National Drug Code	59212-562, 67296-1781, 71205-448